| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |